 |
 |
 |
 |
|
|
|
|
 |
|
|
 |
|
|
|
|
| |
|||||||||||||||||
|
|
|
|
|
|
|
|||||||||||
|
|||||||||||||||||
|
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 11, Number 1, January 2005 Human Parechovirus-3 and Neonatal InfectionsGuy Boivin,* Yacine Abed,* and François D. Boucher* |
|
|
|
 |
|
| Back to article | |
|
Appendix Figure. Comparison of the predicted amino acid sequences of human parechovirus (HPeV)-3 Canadian isolates no. 81235, 81554, and 82853 with reference sequences of HPeV-1, -2 and -3 (GenBank accession no. S45208, AF055846, and AB084913, respectively) for the VP0-VP3-VP1 proteins (8,10). Asterisks denote identical residues in all strains, whereas shaded amino acids highlight changes between HPeV-3 isolates. The RGD motif present only in HPeV-1 and -2 strains is underlined. The HPeV-1 immunodominant epitope described by Joki-Korpela et al. (15) is shown in bold. |
|
|
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
|
This page last reviewed December 15, 2004 |
|
|
Emerging
Infectious Diseases Journal |
|